Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical breast exam contribution to breast cancer diagnosis in BRCA mutation carriers vs. average to intermediate risk women.

Breast cancer research and treatment - 1 Aug 2024

Menes Tehillah S, Zippel Douglas, Sklair-Levy Miri, Friedman Eitan, Bernstein-Molho Rinat, Faermann Renata, Madorsky Feldman Dana

Abstract excerpt

PURPOSE: The contribution of clinical breast exam (CBE) to breast cancer diagnosis in average risk women undergoing regular screening mammography is minimal. To evaluate the role of CBE in high-risk women, we compared BC diagnosis by CBE in BRCA mutation carriers undergoing regular BC surveillance to average to intermediate risk women undergoing regular breast cancer screening. METHODS: A retrospective chart...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Breast Neoplasms

Share to Early Detection of Cancer

Share to Heterozygote

Share to Mammography

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 38797791
DOI: 10.1007/s10549-024-07345-3
PMCID: PMC11230960

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical breast exam contribution to breast cancer diagnosis in BRCA mutation carriers vs. average to intermediate risk women.PMID 38797791Read ↗

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.Semantic proximity Read ↗

The value of clinical breast examination in a breast cancer surveillance program for women with germline BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Incidence of Cancer and Role of Sentinel Lymph Node Biopsy in BRCA Mutation Carriers Undergoing Prophylactic Mastectomies.Semantic proximity Read ↗

Impact of the 2018 ACR Supplemental Screening Recommendations on MRI Eligibility in Breast Cancer Survivors.Semantic proximity Read ↗

MRI phenotypes associated with breast cancer predisposing genetic variants, a multisite review.Semantic proximity Read ↗

The additional cancer yield of clinical breast examination in screening of women at hereditary increased risk of breast cancer: a systematic review.Semantic proximity Read ↗

Imaging Characteristics of Breast Cancers Detected During MRI-Based Surveillance in Hereditary Breast and Ovarian Cancer SyndromeSemantic proximity Read ↗

Abnormal Findings Detected by Multi-modality Breast Imaging and Biopsy Results in a High-risk Clinic.Semantic proximity Read ↗

Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study.Semantic proximity Read ↗

Mammographic Findings, Bi-rads and Their Relationship to Diagnostic Mammography at the University of Maiduguri Teaching Hospital, Borno StateSemantic proximity Read ↗

High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.